Lazertinib mesylate

SKU: orb3027911

Description

Lazertinib (mesylate) (YH25448 (mesylate); GNS-1480 (mesylate)) is an orally active EGFR inhibitor capable of crossing the blood-brain barrier. It suppresses the p-EGFR, p-AKT, and p-ERK signaling pathways, leading to apoptosis. Lazertinib (mesylate) demonstrates antitumor activity in the H1975-luc BM xenograft model in mice and is applicable for researching non-small cell lung cancer.

Research Area

Cardiovascular Research, Signal Transduction

Images & Validation

−

Key Properties

−

CAS Number	2247995-37-3
MW	650.75
Formula	C₃₁H₃₈N₈O₆S
SMILES	O=C(C=C)NC1=CC(NC2=NC=CC(=N2)N3N=C(C=4C=CC=CC4)C(=C3)CN(C)C)=C(OC)C=C1N5CCOCC5.O=S(=O)(O)C
Target	EGFR,ERK,Akt

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

EGFR,ERK,Akt

Protocol Information

Find More Protocols